Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-09 Reid Laurence Director Purchase +19,883 $1.17 $23K 19,883
2026-09-09 Reid Laurence Director Purchase +117 $1.18 $138 20,000
2026-09-08 Wein Matthew See Remarks Sale −358 $1.16 $415 126,133
2026-09-08 Irish Jian See Remarks Sale −2,140 $1.16 $2K 375,393
2026-09-08 Wapnick Pamela Chief Financial Officer Sale −1,911 $1.16 $2K 206,580
2026-06-09 Reid Laurence Director Grant or award · Stock Option (Right to Buy) +17,400 17,400
2026-06-09 Dere Willard H Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2026-06-09 BJERKHOLT ERIC Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2026-06-09 Eckhardt Juergen Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2026-06-05 Wapnick Pamela Chief Financial Officer Sale −2,884 $1.30 $4K 208,491
2026-06-05 Irish Jian See Remarks Sale −3,737 $1.30 $5K 377,533
2026-06-05 Wein Matthew See Remarks Sale −558 $1.30 $725 126,491
2026-04-01 Irish Jian See Remarks Grant or award +46,000 379,770
2026-04-01 Irish Jian See Remarks Grant or award · Stock Option (Right to Buy) +276,000 276,000
2026-04-01 Wein Matthew See Remarks Grant or award +11,000 125,549
2026-04-01 Wein Matthew See Remarks Grant or award · Stock Option (Right to Buy) +68,000 68,000
2026-04-01 Wapnick Pamela Chief Financial Officer Grant or award +24,000 211,375
2026-04-01 Wapnick Pamela Chief Financial Officer Grant or award · Stock Option (Right to Buy) +144,000 144,000
2026-03-05 Wapnick Pamela Chief Financial Officer Sale −1,581 $1.60 $3K 187,375
2026-03-05 Wein Matthew See Remarks Sale −482 $1.60 $771 114,549

Page 1 of 6 · 101 trades